SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-005415
Filing Date
2020-01-29
Accepted
2020-01-29 17:53:27
Documents
2
Period of Report
2020-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 29308
2 POA DOCUMENT poa.txt EX-24.4_890763 10663
  Complete submission text file 0001209191-20-005415.txt   42380
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 36 ROBINSON ROAD, #13-01 CITY HOUSE SINGAPORE U0 068877
Business Address 36 ROBINSON ROAD, #13-01 CITY HOUSE SINGAPORE U0 068877 962 6 582 7999
BioLexis Pte Ltd. (Reporting) CIK: 0001716335 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 20559268

Mailing Address #30, "GALAXY," 1ST MAIN J.P. NAGAR 3RD PHASE BANGALORE K7 560078
Business Address
Pillai Arun Kumar (Reporting) CIK: 0001717437 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 20559267

Mailing Address 7TH CIRCLE, ZAHRAN ST. ZAHRAN PLAZA BUILDING, 4TH FLOOR AMMAN M2 11844
Business Address
Sukhtian Ghiath M. (Reporting) CIK: 0001717441 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 20559266